Pimecrolimus CAS: 137071-32-0
MF: C43H68ClNO11
MW: 810.45
An immunosuppressant asomycin derivative.

Pimecrolimus (CAS 137071-32-0)

Pimecrolimus | CAS 137071-32-0 is rated 5.0 out of 5 by 1.
  • y_2021, m_1, d_17, h_21
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.12
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_208172, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getAggregateRating, 7ms
  • REVIEWS, PRODUCT
5
1
4
0
3
0
2
0
1
0
Alternate Names: 33-Epichloro-33-desoxyascomycin; Elidel
Application: Pimecrolimus is an immunosuppressant asomycin derivative
CAS Number: 137071-32-0
Molecular Weight: 810.45
Molecular Formula: C43H68ClNO11
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data (including water content).

A macrolactam ascomycin derivative which inhibits production of pro-inflammatory cytokines by T cells and mast cells.


References

Gassberger, M., et al.: Br. J. Dermatol., 141, 264 (1999), Queille-Roussel, C., et al.: Contact Dermatitis, 42, 349 (2000),

Physical State :
Solid
Storage :
Store at 4° C
Melting Point :
142-144° C
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
PubChem CID :
6447131

Download SDS (MSDS)

Certificate of Analysis

Adobe Acrobat Reader is required to reliably view,
print and comment on PDF documents

Pimecrolimus (CAS 137071-32-0)  Product Citations

See how others have used Pimecrolimus (CAS 137071-32-0). Click on the entry to view the PubMed entry .

Citations 1 to 2 of 2 total

PMID: # 28400912  Xu, S.|Li, L.|Li, M.|Zhang, M.|Ju, M.|Chen, X.|Gu, H.| et al. 2017. Oxid Med Cell Longev. 2017: 5930639.

PMID: # 30883607  PLoS Pathog. e1007601.

Citations 1 to 2 of 2 total
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getContent, 205ms
  • QUESTIONS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;
Rated 5 out of 5 by from Yoon Yoon, NY. et al. (PubMed 25786383) reported that topical glucocorticoid or Pimecrolimus treatment suppressed thymic stromal lymphopoietin-related allergic inflammatory mechanism in an oxazolone-induced atopic dermatitis murine model. -SCBT Publication Review
Date published: 2015-07-09
  • y_2021, m_1, d_17, h_21
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.12
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_208172, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getReviews, 6ms
  • REVIEWS, PRODUCT

Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2021 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.